Holzer P, Michl T, Danzer M, Jocic M, Schicho R, Lippe I T
Department of Experimental and Clinical Pharmacology, University of Graz, Austria.
J Physiol Pharmacol. 2001 Dec;52(4 Pt 1):505-21.
A dense network of extrinsic and intrinsic sensory neurons supplies the gastrointestinal tract. Intrinsic sensory neurons provide the enteric nervous system with the kind of information that this brain of the gut requires for its autonomic control of digestion, whereas extrinsic afferents notify the brain about processes that are relevant to energy and fluid homeostasis and the sensation of discomfort and pain. The sensory repertoire of afferent neurons is extended by their responsiveness to mediators released from enteroendocrine and immune cells, which act like "taste buds" of the gut and serve as interface between the gastrointestinal lumen and the sensory nerve terminals in the lamina propria of the mucosa. Functional bowel disorders such as non-ulcer dyspepsia and irritable bowel syndrome are characterized by abdominal discomfort or pain in the absence of an identifiable organic cause. It is hypothesized with good reason that infection, inflammation or trauma causes sensory pathways to undergo profound phenotypic and functional alterations that outlast the acute insult. The pertinent changes involve an exaggerated sensitivity of the peripheral afferent nerve fibres as well as a distorted processing and representation of the incoming information in the brain. This concept identifies a number of receptors and ion channels that are selectively expressed by primary afferent neurons as important molecular targets at which to aim novel therapies for functional bowel disorders.
胃肠道由密集的外在和内在感觉神经元网络所支配。内在感觉神经元为肠神经系统提供肠道这个“大脑”自主控制消化所需的信息,而外在传入神经则向大脑通报与能量和液体稳态以及不适与疼痛感觉相关的过程。传入神经元的感觉功能范围因其对肠内分泌细胞和免疫细胞释放的介质的反应能力而得以扩展,这些细胞就像肠道的“味蕾”,并作为胃肠道管腔与黏膜固有层感觉神经末梢之间的界面。功能性肠道疾病,如非溃疡性消化不良和肠易激综合征,其特征是在没有可识别的器质性病因的情况下出现腹部不适或疼痛。有充分理由推测,感染、炎症或创伤会导致感觉通路发生深刻的表型和功能改变,且这些改变在急性损伤后仍会持续。相关变化包括外周传入神经纤维的敏感性增强,以及大脑中对传入信息的处理和表征出现扭曲。这一概念确定了一些由初级传入神经元选择性表达的受体和离子通道,作为针对功能性肠道疾病的新型疗法的重要分子靶点。